RegPing
Primary sources, polled every 30 minutesJSON · Sitemap · llms.txt · Status

FDA · recall · notice

FDA: Par Health recalls Brevital Sodium 500 mg/vial due to particulate matter

Par Health issued a voluntary nationwide recall of two lots of Brevital Sodium 500 mg/vial (Methohexital Sodium for Injection, USP) to the hospital level. The recall was initiated due to the presence of particulate matter identified as cellulose.

Read the notice at fda.gov →

Agency
FDA
Jurisdiction
US-FDA
Action type
recall
Severity
notice — worth a prompt look
Published
Recorded
Tags
recallparticulate-matterinjectablebrevital
Not legal advice. RegPing republishes and summarizes public regulator notices and links to the original. Summaries are produced with a language model and can be wrong; the regulator's text controls. Not legal advice. Consult counsel before acting.

More from FDA

Everything from week 2026-W41 · All FDA alerts